Article ; Online: Theranostic applications of selenium nanomedicines against lung cancer.
2023 Volume 21, Issue 1, Page(s) 96
Abstract: The incidence and mortality rates of lung cancer are among the highest in the world. Traditional treatment methods include surgery, chemotherapy, and radiotherapy. Although rapid progress has been achieved in the past decade, treatment limitations remain. ...
Abstract | The incidence and mortality rates of lung cancer are among the highest in the world. Traditional treatment methods include surgery, chemotherapy, and radiotherapy. Although rapid progress has been achieved in the past decade, treatment limitations remain. It is therefore imperative to identify safer and more effective therapeutic methods, and research is currently being conducted to identify more efficient and less harmful drugs. In recent years, the discovery of antitumor drugs based on the essential trace element selenium (Se) has provided good prospects for lung cancer treatments. In particular, compared to inorganic Se (Inorg-Se) and organic Se (Org-Se), Se nanomedicine (Se nanoparticles; SeNPs) shows much higher bioavailability and antioxidant activity and lower toxicity. SeNPs can also be used as a drug delivery carrier to better regulate protein and DNA biosynthesis and protein kinase C activity, thus playing a role in inhibiting cancer cell proliferation. SeNPs can also effectively activate antigen-presenting cells to stimulate cell immunity, exert regulatory effects on innate and regulatory immunity, and enhance lung cancer immunotherapy. This review summarizes the application of Se-based species and materials in lung cancer diagnosis, including fluorescence, MR, CT, photoacoustic imaging and other diagnostic methods, as well as treatments, including direct killing, radiosensitization, chemotherapeutic sensitization, photothermodynamics, and enhanced immunotherapy. In addition, the application prospects and challenges of Se-based drugs in lung cancer are examined, as well as their forecasted future clinical applications and sustainable development. |
---|---|
MeSH term(s) | Humans ; Selenium/therapeutic use ; Selenium/metabolism ; Precision Medicine ; Nanomedicine ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Antioxidants/metabolism ; Nanoparticles/therapeutic use ; Drug Carriers |
Chemical Substances | Selenium (H6241UJ22B) ; Antioxidants ; Drug Carriers |
Language | English |
Publishing date | 2023-03-20 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 2100022-0 |
ISSN | 1477-3155 ; 1477-3155 |
ISSN (online) | 1477-3155 |
ISSN | 1477-3155 |
DOI | 10.1186/s12951-023-01825-2 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.